In order to connect Apollo Hospitals‘ AICVD tool with ConnectedLife’s digital solutions for wellness, condition management, and other health-focused applications, the two organizations have established a novel partnership. ConnectedLife is a leader in the use of motor state diagnostics. The risk of cardiovascular disease can be predicted using the AICVD program. This will give medical professionals the power to identify people who are at an increased risk for developing heart disease and to start treatment before it is too late to make a significant difference.

During the digital event to announce the alliance, the clinical integration was displayed. The cardiac risk scoring tool is exceptional in how quickly it processes data and how accurately it forecasts a patient’s likelihood of acquiring the coronary disease. By using the technology, doctors may provide proactive, preemptive, and preventative care for people who are at risk, improving lives while reducing future life-threatening dangers and easing the burden on healthcare systems.

In order to provide healthcare professionals with an all-inclusive tool for predicting risk and delivering best-in-class clinical outcomes, the collaboration with ConnectedLife brings together their experience and skills in developing predictive AI tools with ConnectedLife’s healthcare solutions.

A personal care plan can be created and given to a patient using this dynamic ConnectedLife-enabled capability. Doctors can also digitally monitor patient compliance, objectively measure progress with recommended lifestyle modifications, and improve wellness and health vitals, lowering the risk of cardiac disease.

The team at ConnectedLife is at present managing the deployment of its solutions with over 50 healthcare partners worldwide and Apollo’s Clinical AICVD tool will automatically be available and operational to all customers.

For more details log onto: www.apollohospitals.com